| Poxvirus cancer therapy. | |
| | |
MedLine Citation:
|
PMID: 18221156 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Despite many advances in chemotherapy and other medical techniques, patients with cancer often develop local recurrence or metastatic spread. Recent advances in molecular biology and tumor immunology have led to the design of many new anti-tumor vaccines. Such approaches are now using recombinant viruses to treat different types of cancer. From these new developments, innovative fields are emerging: vaccine virotherapy, viral immunotherapy, oncolytic virotherapy and drug virotherapy. Many viruses are currently exploited as recombinant vectors and each offers natural or synthetic characteristics that may provide unique means to treat cancer. Poxviruses are large double stranded DNA viruses that offer many advantageous characteristics as recombinant vectors. Poxvirus-based vectors offer essentially unlimited possibilities for genetic manipulation due to the large size of their DNA and high degree of safety. Vaccinia virus, the prototype virus of the Orthopoxvirus genus that was extensively used to eradicate Smallpox, and other poxviruses are now being considered and used for the treatment of cancer. This review will cover their utilization as anti-cancer therapeutics by describing recent patents (2000-2005). |
| | |
Authors:
|
Philippe-Alexandre Gilbert; Grant McFadden |
Related Documents
:
|
23419136 - Resource utilization in cancer patients with bisphosphonate-associated osteonecrosis of... 16033526 - Blood brothers: carbohydrates in xenotransplantation and cancer immunotherapy. 23263696 - Interpersonal influences and attitudes about adjuvant therapy treatment decisions among... 23737606 - Cancer cachexia pathophysiology and translational aspect of herbal medicine. 16117016 - Chemotherapy-induced nausea and vomiting: prevention, detection, and treatment--how are... 12901236 - Bms-247550 bristol-myers squibb/gbf. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Review |
Journal Detail:
|
Title: Recent patents on anti-infective drug discovery Volume: 1 ISSN: 1574-891X ISO Abbreviation: - Publication Date: 2006 Nov |
Date Detail:
|
Created Date: 2008-01-28 Completed Date: 2008-02-21 Revised Date: 2009-01-22 |
Medline Journal Info:
|
Nlm Unique ID: 101266084 Medline TA: Recent Pat Antiinfect Drug Discov Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 309-21 Citation Subset: IM |
Affiliation:
|
Robarts Research Institute, BioTherapeutics Research Group, Siebens-Drake Building Room 133, 1400 Western Road, London, Ontario, Canada N6G 2V4. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antigens, Neoplasm
/
immunology Cancer Vaccines* Genetic Vectors Humans Neoplasms / immunology, therapy* Poxviridae / genetics*, immunology |
| Chemical | |
Reg. No./Substance:
|
0/Antigens, Neoplasm; 0/Cancer Vaccines |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: SARS coronavirus anti-infectives.
Next Document: Recent patents on nucleoside and nucleotide inhibitors for HCV.